Treatment of Scalp Eczema
Start with topical corticosteroids applied no more than twice daily to the affected scalp areas, using the least potent preparation that adequately controls symptoms. 1, 2
First-Line Treatment Approach
Topical Corticosteroids
- Apply betamethasone valerate lotion or similar corticosteroid formulations to the scalp twice daily (morning and night), massaging lightly until absorbed. 2
- Use the least potent preparation required to maintain control - this is the fundamental principle of eczema management. 3, 1
- Potent and very potent corticosteroids should be reserved for limited periods only, with implementation of "steroid holidays" (short breaks) when possible to minimize side effects. 3, 1
- Treatment should not be applied more than twice daily; many newer preparations are effective with once-daily application. 3
- Topical corticosteroids remain the therapeutic agent of choice for all scalp eczema presentations. 4
Essential Adjunctive Measures
- Liberal and regular application of emollients is the cornerstone of maintenance therapy, even when the eczema appears controlled. 1
- Apply emollients after bathing to provide a surface lipid film that retards water loss. 1
- Use soap-free cleansers and avoid alcohol-containing products on the scalp. 1
- Regular bathing for cleansing and hydrating the skin is recommended. 1
Managing Pruritus
- Sedating antihistamines (such as hydroxyzine or diphenhydramine) may help with nighttime itching through their sedative properties, not through direct anti-pruritic effects. 1
- Use sedating antihistamines at bedtime only; avoid daytime use. 3
- Large doses may be required in children. 3
- Non-sedating antihistamines have little to no value in atopic eczema and should not be used. 3, 1
Managing Secondary Infections
Bacterial Infections
- Watch for signs of secondary bacterial infection: increased crusting, weeping, or pustules. 1
- Flucloxacillin is the first-line oral antibiotic for Staphylococcus aureus, the most common pathogen in infected eczema. 3, 1
- Erythromycin should be used in patients with penicillin allergy or flucloxacillin resistance. 3
- Phenoxymethylpenicillin is indicated if β-hemolytic streptococci are isolated. 3
- Continue topical corticosteroids during bacterial infection when appropriate systemic antibiotics are given concurrently - do not withhold anti-inflammatory treatment. 1
Viral Infections (Eczema Herpeticum)
- If you observe grouped vesicles, punched-out erosions, or sudden deterioration with fever, suspect eczema herpeticum - this is a medical emergency. 1, 5
- Initiate oral acyclovir early in the disease course. 3, 1, 5
- In ill, feverish patients, administer acyclovir intravenously immediately. 3, 1, 5
Alternative Topical Agents
Tar Preparations
- Ichthammol (1% in zinc ointment) is less irritant than coal tar and may be particularly useful for healing lichenified eczema. 3
- Coal tar solution (1% strength) is generally preferred to crude coal tar. 3
- These agents do not cause systemic side effects related to percutaneous absorption unless used extravagantly. 3
Newer Anti-Inflammatory Options
- Recent network meta-analysis evidence shows potent topical corticosteroids, JAK inhibitors (ruxolitinib 1.5%), and tacrolimus 0.1% rank amongst the most effective treatments for eczema. 6
- PDE-4 inhibitors (crisaborole 2%, roflumilast 0.15%) rank amongst the least effective treatments. 6
- Tacrolimus 0.1% and pimecrolimus 1% are more likely to cause application-site reactions compared to corticosteroids. 6
Critical Safety Considerations
Corticosteroid-Related Concerns
- The main risk with topical corticosteroids is pituitary-adrenal axis suppression, particularly with prolonged use of potent preparations over large surface areas. 3, 2
- Short-term use (median 3 weeks, range 1-16 weeks) of mild to very potent topical corticosteroids shows no evidence for increased skin thinning. 6
- Longer-term use (6-60 months) does show increased skin thinning with mild to potent corticosteroids. 6
- Patients' or parents' fears of steroids often lead to undertreatment - explain the different potencies and the benefits/risks clearly to ensure compliance. 3, 1
Application Precautions
- Avoid occlusive dressings unless specifically directed, as they enhance systemic absorption. 2
- Pediatric patients may absorb proportionally larger amounts and are more susceptible to systemic toxicity. 2
- If irritation develops, discontinue topical corticosteroids and institute appropriate therapy. 2
When to Refer or Escalate
- Failure to respond to first-line management with moderate potency topical corticosteroids after 4 weeks is an indication for referral to a hospital specialist. 3, 1
- Need for systemic therapy or phototherapy requires specialist evaluation. 1
- Suspected eczema herpeticum requires immediate emergency treatment. 1, 5
- Systemic corticosteroids have a limited but definite role only for tiding occasional patients with severe atopic eczema through acute crises, after all other treatment avenues have been explored. 3, 1
- Systemic corticosteroids should never be used for maintenance treatment. 3, 1
Common Pitfalls to Avoid
- Do not delay or withhold topical corticosteroids when infection is present - they remain the primary treatment when appropriate systemic antibiotics are given concurrently. 1
- Do not use topical corticosteroids continuously without implementing "steroid holidays" when possible. 1
- Do not use systemic corticosteroids for chronic maintenance - they should only "tide over" acute severe flares. 7
- Ensure patients understand that treatment requires consistent, long-term application even when symptoms improve. 8